Insights

Innovative Focus ReviR Therapeutics specializes in advanced RNA-targeted therapies utilizing AI and machine learning, providing opportunities to collaborate with biopharmaceutical companies seeking cutting-edge treatments for neurogenetic disorders and rare diseases.

Recent Funding & Growth Having secured $30 million in Series A funding and ongoing collaborations, ReviR is expanding its R&D capabilities, which presents potential for investment or partnership in early-stage drug development projects.

Disease Specialization With a focus on neurogenetic diseases such as Kennedy's Disease and Charcot-Marie-Tooth, there is a market for specialized therapeutic solutions, appealing to organizations targeting rare and underserved medical conditions.

Strategic Partnerships ReviR's collaborations with non-profit foundations and pharmaceutical companies indicate openness to joint ventures and licensing opportunities to accelerate therapy commercialization.

Technology-Driven Solutions Their use of advanced tech stacks and AI platforms allows for scalable, novel target discovery, offering potential for licensable platforms or bespoke solutions tailored to pharma R&D pipelines.

ReviR Therapeutics Tech Stack

ReviR Therapeutics uses 8 technology products and services including Amazon Web Services, Google Workspace, Element UI, and more. Explore ReviR Therapeutics's tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • Google Workspace
    Email
  • Element UI
    Javascript Frameworks
  • Vue.js
    Javascript Frameworks
  • Swiper
    Javascript Libraries
  • Lodash
    Javascript Libraries
  • Ubuntu
    Operating Systems
  • Nginx
    Web Servers

Media & News

ReviR Therapeutics's Email Address Formats

ReviR Therapeutics uses at least 1 format(s):
ReviR Therapeutics Email FormatsExamplePercentage
First.Last@revirtx.comJohn.Doe@revirtx.com
44%
First@revirtx.comJohn@revirtx.com
10%
F.Last@revirtx.comJ.Doe@revirtx.com
2%
First.Last@revirtx.comJohn.Doe@revirtx.com
44%

Frequently Asked Questions

What is ReviR Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
ReviR Therapeutics's official website is revirtx.com and has social profiles on LinkedInCrunchbase.

What is ReviR Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
ReviR Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ReviR Therapeutics have currently?

Minus sign iconPlus sign icon
As of December 2025, ReviR Therapeutics has approximately 20 employees across 3 continents, including North AmericaAsiaSouth America. Key team members include Vp Of Computing: Y. L.Co-Founder & Chairman: Y. L.Vice President: S. N.. Explore ReviR Therapeutics's employee directory with LeadIQ.

What industry does ReviR Therapeutics belong to?

Minus sign iconPlus sign icon
ReviR Therapeutics operates in the Biotechnology Research industry.

What technology does ReviR Therapeutics use?

Minus sign iconPlus sign icon
ReviR Therapeutics's tech stack includes Amazon Web ServicesGoogle WorkspaceElement UIVue.jsSwiperLodashUbuntuNginx.

What is ReviR Therapeutics's email format?

Minus sign iconPlus sign icon
ReviR Therapeutics's email format typically follows the pattern of First.Last@revirtx.com. Find more ReviR Therapeutics email formats with LeadIQ.

How much funding has ReviR Therapeutics raised to date?

Minus sign iconPlus sign icon
As of December 2025, ReviR Therapeutics has raised $4.6M in funding. The last funding round occurred on Jan 30, 2025 for $4.6M.

When was ReviR Therapeutics founded?

Minus sign iconPlus sign icon
ReviR Therapeutics was founded in 2021.

ReviR Therapeutics

Biotechnology ResearchCalifornia, United States11-50 Employees

ReviR Therapeutics is a research and development company whose mission is to harness advanced technologies, machine learning/AI, and the inherent biology embedded within RNA to develop novel medicines to treat human disease.  Our AI-based platform allows us to expand beyond the protein-based target space to reach a large number of known disease targets previously considered “undruggable”

Strategies
* Invent and build technologies to unlock first-in-class medicines for the treatment of cancer, rare genetic disorders, and infectious diseases
* Decipher disease relevant structural and functional RNA motifs by integrating human genetic data, functional genomics, and AI 
* Integrate Machine Learning tools and advanced the mechanistic understanding of the RNA life cycle at scale in order to deliver transformative therapies for millions of patients

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2021
Employees
11-50

Section iconFunding & Financials

  • $4.6M

    ReviR Therapeutics has raised a total of $4.6M of funding over 4 rounds. Their latest funding round was raised on Jan 30, 2025 in the amount of $4.6M.

  • $1M$10M

    ReviR Therapeutics's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $4.6M

    ReviR Therapeutics has raised a total of $4.6M of funding over 4 rounds. Their latest funding round was raised on Jan 30, 2025 in the amount of $4.6M.

  • $1M$10M

    ReviR Therapeutics's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.